Pakistan fears a shortage of life-saving drugs in the wake of the ‘worst economic crisis’

Abstract

Objective: In this study, we examine the issue in the context of Pakistan’s current economic situation, which is leading to a scarcity of essential goods like the raw materials used to create pharmaceuticals that save lives. Finding the problem’s root causes, consequences, and potential countermeasures. Methods: It is crucial to shed light on the efforts and challenges surrounding this topic to build and implement solutions based on research and accurately reflect the health industry’s current situation in light of Pakistan’s economic crisis. This brief summary follows standard procedures used in research papers, and we conducted extensive literature searches using PubMed, Google Scholar, Journals Online, and the Internet Library. Results: ‘Drug scarcity in Pakistan’ yielded anticipated results. Pakistan’s population is growing rapidly, and so is its demand for and consumption of commodities. The economic collapse damaged foreign money and letters of credit, restricting the raw supplies of pharmaceutical materials from standing at port. These holdups are hindering the pharmaceutical industry from meeting patient demand for key drugs, which has a negative impact on the healthcare system as a whole. Conclusion: The pharmaceutical business was already struggling to keep up with demand before the current economic crisis. To avert life-threatening medicine shortages, policymakers must improve the supply chain, incentivize manufacturers to use effective quality control measures, and boost production. Medical personnel must be well-informed and trained to lessen health risks on the front lines.